US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 1.1700
  • +0.0600+5.41%
Close Sep 27 16:00 ET
  • 1.1700
  • 0.00000.00%
Post 16:09 ET
215.37MMarket Cap-1300P/E (TTM)

Nektar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nektar Therapeutics Q2 2024 Earnings Date

Currency：USDAug 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
17.55M
23.49M
+5.94M
Beat Est.
-14.41%
+14.59%
+33.88%
EPS
-0.20
-0.25
-0.05
Miss Est.
+24.38%
+7.41%
-22.49%
Analyst Rating
No Data

Nektar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 16.116M--
--2024/Q3-- / 17.141M--
Aug 8, 20242024/Q223.489M / 17.545M--
May 9, 20242024/Q121.639M / 15.342M--
Mar 4, 20242023/Q423.885M / 21.368M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 16.116M--
--2024/Q3-- / 17.141M--
Aug 8, 20242024/Q223.489M / 17.545M--
May 9, 20242024/Q121.639M / 15.342M--
Mar 4, 20242023/Q423.885M / 21.368M--

Unlock Free Earnings Estimates

Nektar Therapeutics Earnings Reports

  • Nektar Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 14:07 ET

  • Nektar Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 10 14:13 ET

  • Nektar Therapeutics | 10-K: FY2023 Annual Report

    Mar 5 17:16 ET

  • Nektar Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 17:54 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data